Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124712962 | 12471296 | 2 | F | 20160318 | 20160816 | 20160616 | 20160819 | EXP | US-PFIZER INC-2016276875 | PFIZER | 60.00 | YR | F | Y | 0.00000 | 20160819 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124712962 | 12471296 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | 10 MG, 3X/DAY | Y | 20235 | 10 | MG | TID | |||||||
| 124712962 | 12471296 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Y | 20235 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124712962 | 12471296 | 1 | Seizure |
| 124712962 | 12471296 | 2 | Neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124712962 | 12471296 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124712962 | 12471296 | Cognitive disorder | |
| 124712962 | 12471296 | Feeling abnormal | |
| 124712962 | 12471296 | Nausea | |
| 124712962 | 12471296 | Retinal exudates |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124712962 | 12471296 | 1 | 20160318 | 0 |